b88b2960c0763a27690d5d3313ac894a3cb5272c1f22de2e228da66286dc0ea4 2024-458-1/data/2024-08-24_proteomic_oxilipids_BRSV_to_NDS_BAL_oxylipids_pg_ml.tsv
257f2a958219c73a30fc7bf1f9170de9e7956da64b48cdd12e0db67b28ba45fe 2024-458-1/data/2024-08-24_proteomic_oxilipids_BRSV_to_NDS_BAL_proteins_LFQ.tsv
22b3f24c280eb6fc61c10b8b0ea55e1aa475ec6fbda0859e9c4513c1e084ac34 2024-458-1/data/2024-08-24_proteomic_oxilipids_BRSV_to_NDS_plasma_oxylipids_pg_ml.tsv
d709ab686647dbd9ff3068fef8d7d6ac161f3aef44e78d759b00caa6ca0dddd5 2024-458-1/data/2024-08-24_proteomic_oxilipids_BRSV_to_NDS.xlsx
27f440e17dad5cb50e76b09b8a8412a8e415640c20a26b36f7a5c10104a08333 2024-458-1/documentation/NDS_Effect_of_NSAIDs_on_the_pulmonary_proteome_and_oxylipids_during_BRSV_infection_BAL_oxylipids.txt
5d96bc8303e587013821679c9668c2058b4bed424da3426348ce56087f713f3b 2024-458-1/documentation/NDS_Effect_of_NSAIDs_on_the_pulmonary_proteome_and_oxylipids_during_BRSV_infection_BAL_proteins.txt
4af86d9e6fbb08f6ed4e45d9702abc0c9f82242ceffe3774f1a50d2efe134780 2024-458-1/documentation/NDS_Effect_of_NSAIDs_on_the_pulmonary_proteome_and_oxylipids_during_BRSV_infection_plasma_oxylipids.txt
